Home » Stocks » ESTA

Establishment Labs Holdings Inc. (ESTA)

Stock Price: $69.19 USD -2.88 (-4.00%)
Updated Apr 16, 2021 4:00 PM EDT - Market closed
Market Cap 1.64B
Revenue (ttm) 84.68M
Net Income (ttm) -38.12M
Shares Out 23.69M
EPS (ttm) -1.64
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day April 16
Last Price $69.19
Previous Close $72.07
Change ($) -2.88
Change (%) -4.00%
Day's Open 72.34
Day's Range 67.54 - 72.98
Day's Volume 59,532
52-Week Range 13.87 - 76.91

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of -35.29% and -0.14%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead fo...

1 month ago - Zacks Investment Research

Shares of Establishment Labs Hldgs (NASDAQ:ESTA) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share rose 14.81% year over year to ($0.23), which missed the estima...

1 month ago - Benzinga

SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women's health, initially in the breast aesthetics and reconstruction mar...

1 month ago - Business Wire

Establishment Labs Hldgs (NASDAQ:ESTA) announces its next round of earnings this Wednesday, March 10. Here is Benzinga's look at Establishment Labs Hldgs's Q4 earnings report.

1 month ago - Benzinga

SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women's health, initially in the breast aesthetics and reconstruction mar...

1 month ago - Business Wire

SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women's health, initially in the breast aesthetics and reconstruction mar...

1 month ago - Business Wire

SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women's health, initially in the breast aesthetics and reconstruction mar...

2 months ago - Business Wire

SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women's health, initially in the breast aesthetics and reconstruction mar...

2 months ago - Business Wire

SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women's health, initially in the breast aesthetics and reconstruction mar...

2 months ago - Business Wire

As of late, it has definitely been a great time to be an investor in Establishment Labs Holdings (ESTA).

2 months ago - Zacks Investment Research

Establishment Labs (ESTA) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

2 months ago - Zacks Investment Research

SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women's health, initially in the breast aesthetics and reconstruction mar...

2 months ago - Business Wire

SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women's health, initially in the breast aesthetics and reconstruction mar...

3 months ago - Business Wire

SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women's health, initially in the breast aesthetics and reconstruction mar...

3 months ago - Business Wire

SANTA BARBARA, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women's health, initially in the breast aesthetics and r...

4 months ago - GlobeNewsWire

Establishment Labs Holdings, Inc. (ESTA) CEO Juan José Chacón Quirós on Q3 2020 Results - Earnings Call Transcript

5 months ago - Seeking Alpha

SANTA BARBARA, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women's health, initially in the breast aesthetics and r...

5 months ago - GlobeNewsWire

SANTA BARBARA, Calif., Oct. 21, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women's health, initially in the breast aesthetics and r...

5 months ago - GlobeNewsWire

Event to Feature Members of Company’s Medical and Scientific Advisory Boards and U.S. IDE Medical Director Event to Feature Members of Company’s Medical and Scientific Advisory Boards and U.S. IDE Medic...

6 months ago - GlobeNewsWire

SANTA BARBARA, Calif., Sept. 25, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics an...

6 months ago - GlobeNewsWire

SANTA BARBARA, Calif., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics an...

6 months ago - GlobeNewsWire

NEW YORK, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruct...

7 months ago - GlobeNewsWire

Establishment Labs Holdings Inc. (ESTA) CEO Juan José Chacón-Quirós on Q2 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

Establishment Labs Holdings Inc. (ESTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

8 months ago - Zacks Investment Research

NEW YORK, July 23, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (Nasdaq: ESTA), a medical technology company focused on Women’s Health, initially in the breast aesthetics and reconstructi...

8 months ago - GlobeNewsWire

NEW YORK, June 11, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstructi...

10 months ago - GlobeNewsWire

Establishment Labs Holdings Inc. (ESTA) CEO Juan José Chacón-Quirós on Q1 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

As of late, it has definitely been a great time to be an investor Establishment Labs

11 months ago - Zacks Investment Research

Medical Services Outlook Bright Amid Coronavirus Crisis

Other stocks mentioned: CODX, NVCR, OCX
1 year ago - Zacks Investment Research

NEW YORK, March 25, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruct...

1 year ago - GlobeNewsWire

Establishment Labs Holdings, Inc. (ESTA) CEO Juan Jose Chacon Quiros on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

NEW YORK, Feb. 03, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a medical technology company focused on Women’s Health – initially in the breast aesthetics...

1 year ago - GlobeNewsWire

NEW YORK, Jan. 29, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a medical technology company focused on Women’s Health – initially in the breast aesthetics...

1 year ago - GlobeNewsWire

NEW YORK, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruct...

1 year ago - GlobeNewsWire

Establishment Labs Holdings, Inc. (ESTA) CEO Juan Jose Chacon Quiros on Q3 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of -19.23% and 14.27%, respectively, for the quarter ended September 2019.

1 year ago - Zacks Investment Research

Establishment Labs Holdings Inc. (ESTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

1 year ago - Zacks Investment Research

Science, technology, safety and clinical outcomes of Motiva Implants® showcased as symposium breaks attendance records Science, technology, safety and clinical outcomes of Motiva Implants® showcased as ...

1 year ago - GlobeNewsWire

NEW YORK, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruct...

1 year ago - GlobeNewsWire

NEW YORK, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstructi...

1 year ago - GlobeNewsWire

Establishment Labs Holdings Inc. (ESTA) CEO Juan José Chacón-Quirós on Q2 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of 15.38% and 7.88%, respectively, for the quarter ended June 2019.

1 year ago - Zacks Investment Research

Establishment Labs Holdings Inc. (ESTA) CEO Juan José Chacón-Quirós on Q1 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Establishment Labs (ESTA) has taken the breast implant industry by storm with its next level technology, 6th generation, Motiva Implants.

1 year ago - Seeking Alpha

Establishment Labs Holdings Inc. (ESTA) CEO Juan José Chacón-Quirós on Q4 2018 Results - Earnings Call Transcript

2 years ago - Seeking Alpha

About ESTA

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand. It also provides Divina 3D surgical simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribut... [Read more...]

Industry
Medical Devices
IPO Date
Jul 19, 2018
CEO
Juan Jose Chacon Quiros
Employees
521
Stock Exchange
NASDAQ
Ticker Symbol
ESTA
Full Company Profile

Financial Performance

In 2020, ESTA's revenue was $84.68 million, a decrease of -5.46% compared to the previous year's $89.57 million. Losses were -$38.12 million, -0.08% less than in 2019.

Financial Statements

Analyst Forecasts

According to 6 analysts, the average rating for ESTA stock is "Strong Buy." The 12-month stock price forecast is 76.33, which is an increase of 10.32% from the latest price.

Price Target
$76.33
(10.32% upside)
Analyst Consensus: Strong Buy